What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.35%Above 5Y avg (0.84%)
Annual Rate
EUR 0.98Paid annual
Payout Ratio
25.1%Sustainable
Payback Period
76.0 yr
Last Ex-Dividend
Jun 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.58BEUR
9.93B · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
18.69x
vs Diagnostics & Research peers
Updated Aug 19, 2026
Revenue (TTM)
3.99BEUR
4.62B · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
11.59%
vs Diagnostics & Research peers
Updated Aug 19, 2026
Beta
0.5700x
vs all stocks
Updated Aug 19, 2026
52-Week Change
-43.45%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
8.58BEUR
9.93B · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
8.35BEUR
9.66B · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
18.69x
vs Diagnostics & Research peers
Updated Aug 19, 2026
Forward P/E
15.63x
vs Diagnostics & Research peers
Updated Aug 19, 2026
Price to Sales (TTM)
2.15x
vs Diagnostics & Research peers
Updated Aug 19, 2026
Price to Book (MRQ)
2.00x
vs Diagnostics & Research peers
Updated Aug 19, 2026
Enterprise to Revenue
2.09x
vs Diagnostics & Research peers
Updated Aug 19, 2026
Enterprise to EBITDA
7.94x
vs Diagnostics & Research peers
Updated Aug 19, 2026
Profit Margin
11.59%
vs Diagnostics & Research peers
Updated Aug 19, 2026
Operating Margin
15.23%
vs Diagnostics & Research peers
Updated Aug 19, 2026
Return on Assets (TTM)
7.23%
vs Diagnostics & Research peers
Updated Aug 19, 2026
Return on Equity (TTM)
11.22%
vs Diagnostics & Research peers
Updated Aug 19, 2026
Revenue (TTM)
3.99BEUR
4.62B · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
33.91EURUpdated Aug 19, 2026
Quarterly Revenue Growth
-3.90%
vs Diagnostics & Research peers
Updated Aug 19, 2026
Gross Profit (TTM)
2.24BEUR
2.59B · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
1.03BEUR
1.19B · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
462.60MEUR
535.46M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
40.40%
vs Diagnostics & Research peers
Updated Aug 19, 2026
Operating Cash Flow (TTM)
905.10MEUR
1.05B · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
589.21MEUR
682.01M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing Annual Dividend Rate
0.9800EURUpdated Aug 19, 2026
Trailing Annual Dividend Yield
1.35%
vs all stocks
Updated Aug 19, 2026
5-Year Average Dividend Yield
0.84%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
25.13%
vs Diagnostics & Research peers
Updated Aug 19, 2026
Minority Interest (Equity)
3.90MEURFY2025 · Dec 31, 2025
Revenue
4.07BEURFY2025 · Dec 31, 2025
Cost of Goods Sold
1.76BEURFY2025 · Dec 31, 2025
Gross Profit
2.31BEURFY2025 · Dec 31, 2025
Operating Income
694.70MEUR
804.12M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
525.70MEURFY2025 · Dec 31, 2025
Income Tax Expense
128.80MEURFY2025 · Dec 31, 2025
Net Income
396.90MEURFY2025 · Dec 31, 2025
EBIT
541.50MEURFY2025 · Dec 31, 2025
EBITDA (Income Statement)
1.03BEURFY2025 · Dec 31, 2025
Research & Development
507.40MEURFY2025 · Dec 31, 2025
Selling, General & Administrative
1.11BEURFY2025 · Dec 31, 2025
Other Operating Expenses
-23.40MEURFY2025 · Dec 31, 2025
Non-operating Interest Income
700.00KEURFY2025 · Dec 31, 2025
Non-operating Interest Expense
15.80MEURFY2025 · Dec 31, 2025
Net Income from Continuing Operations
396.90MEURFY2025 · Dec 31, 2025
Minority Interests (P&L)
600.00KEURFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00EURFY2025 · Dec 31, 2025
Operating Cash Flow
364.10MEURFY2025 · Dec 31, 2025
Free Cash Flow
39.20MEURFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
565.10MEURFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
396.90MEURFY2025 · Dec 31, 2025
Stock-based Compensation
26.50MEURFY2025 · Dec 31, 2025
Other Non-cash Items
15.40MEURFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-29.00MEURFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-45.70MEURFY2025 · Dec 31, 2025
Capital Expenditures
-324.90MEURFY2025 · Dec 31, 2025
Net Acquisitions
-5.20MEURFY2025 · Dec 31, 2025
Purchase of Investments
-1.00MEURFY2025 · Dec 31, 2025
Other Investing Activity
-130.60MEURFY2025 · Dec 31, 2025
Net Investing Cash Flow
-461.70MEURFY2025 · Dec 31, 2025
Long-term Debt Issuance
33.60MEURFY2025 · Dec 31, 2025
Long-term Debt Payments
-63.20MEURFY2025 · Dec 31, 2025
Common Dividends Paid
-106.10MEURFY2025 · Dec 31, 2025
Other Financing Charges
-1.50MEURFY2025 · Dec 31, 2025
Net Financing Cash Flow
-137.20MEURFY2025 · Dec 31, 2025
Shares Outstanding
117.99MSharesUpdated Aug 19, 2026
Float Shares
40.02MSharesUpdated Aug 19, 2026
% Held by Insiders
66.46%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
16.96%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
657.70MEUR
761.29M · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
5.59EURUpdated Aug 19, 2026
Total Debt (MRQ)
421.80MEUR
488.23M · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.0981x
vs Diagnostics & Research peers
Updated Aug 19, 2026
Current Ratio (MRQ)
2.30x
vs Diagnostics & Research peers
Updated Aug 19, 2026
Book Value per Share (MRQ)
36.51EURUpdated Aug 19, 2026
Total Assets
5.57BEUR
6.45B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.54BEURFY2025 · Dec 31, 2025
Total Liabilities
1.47BEURFY2025 · Dec 31, 2025
Total Non-current Assets
3.03BEURFY2025 · Dec 31, 2025
Total Non-current Liabilities
404.00MEURFY2025 · Dec 31, 2025
Total Current Liabilities
1.06BEURFY2025 · Dec 31, 2025
Cash
257.70MEURFY2025 · Dec 31, 2025
Cash Equivalents
312.10MEURFY2025 · Dec 31, 2025
Cash & Cash Equivalents
569.80MEURFY2025 · Dec 31, 2025
Accounts Receivable
766.10MEURFY2025 · Dec 31, 2025
Inventory
959.70MEURFY2025 · Dec 31, 2025
Accounts Payable
262.10MEURFY2025 · Dec 31, 2025
Short-term Debt
131.40MEURFY2025 · Dec 31, 2025
Other Current Liabilities
101.00MEURFY2025 · Dec 31, 2025
Long-term Debt
330.00MEURFY2025 · Dec 31, 2025
Common Stock (Book)
12.00MEURFY2025 · Dec 31, 2025
Retained Earnings
397.50MEURFY2025 · Dec 31, 2025
Total Shareholders' Equity
4.11BEUR
4.75B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
40.00MEURFY2025 · Dec 31, 2025
52-Week Low
65.60EURUpdated Aug 19, 2026
52-Week High
128.30EURUpdated Aug 19, 2026
52-Week Change
-43.45%
vs all stocks
Updated Aug 19, 2026
Beta
0.5700x
vs all stocks
Updated Aug 19, 2026
50-Day MA
70.63EURUpdated Aug 19, 2026
200-Day MA
88.48EURUpdated Aug 19, 2026
Avg 10-Day Volume
121.95KSharesUpdated Aug 19, 2026
Avg 30-Day Volume
165.48KSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
3.90EURUpdated Aug 19, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.